Top 10 Companies in the (S)-Trifluoroisopropylamine (CAS 125278-10-6) Market (2026): Market Leaders Powering Global Growth

MARKET INSIGHTS

Global (S)-Trifluoroisopropylamine (CAS 125278-10-6) market size was valued at USD 18.4 million in 2025. The market is forecast to grow from USD 19.8 million in 2026 to USD 38.6 million by 2034, exhibiting a CAGR of 8.7% during the forecast period.

(S)-Trifluoroisopropylamine (CAS 125278-10-6) Market – View in Detailed Research Report

(S)-Trifluoroisopropylamine is a chiral fluorinated building block with the molecular formula C₃H₆F₃N, widely utilized in pharmaceutical synthesis and agrochemical research. Its unique trifluoromethyl group imparts distinctive physicochemical properties – including enhanced metabolic stability, improved membrane permeability, and increased lipophilicity – making it a highly sought‑after intermediate in the development of active pharmaceutical ingredients (APIs) and specialty chemicals.

The market is gaining steady momentum driven by the growing demand for fluorinated compounds in drug discovery pipelines and the expanding adoption of chiral synthesis technologies. Furthermore, the rising prevalence of conditions requiring precision therapeutics has accelerated research into enantiomerically pure intermediates, of which (S)-Trifluoroisopropylamine is a notable example. Key suppliers operating in this space include TCI Chemicals, Oakwood Chemical, and Apollo Scientific, among others, each offering the compound in varying grades to serve both research and commercial‑scale production requirements.

---

🔟 1. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Pharmaceutical‑grade (S)-Trifluoroisopropylamine with >99% ee, GMP‑certified production lines

Tokyo Chemical Industry has positioned itself as a benchmark for chiral fluorinated intermediates, leveraging decades of experience in asymmetric synthesis and fluorination chemistry. Its flagship product streamlines the development of kinase inhibitors and antiviral agents, providing a single‑step entry point for complex chiral architectures.

Sustainability Initiatives:

• Adoption of continuous flow fluorination to reduce solvent usage and waste generation.
• Implementation of renewable energy sources in manufacturing facilities.
• Commitment to ISO 14001 environmental management standards.

---

9️⃣ 2. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: High‑purity (S)-Trifluoroisopropylamine for CNS and oncology pipelines, cGMP‑compliant supply

Merck’s extensive R&D portfolio and robust manufacturing infrastructure enable rapid scale‑up for late‑stage drug candidates. The company’s focus on chiral purity ensures consistent batch performance across multi‑milligram to kilogram scales.

Sustainability Initiatives:

• Integration of waste‑to‑energy systems in production lines.
• Targeted reduction of carbon footprint by 15% over five years.
• Investment in green chemistry research partnerships.

---

8️⃣ 3. Synthonix Inc.

Headquarters: San Diego, USA
Key Offering: Custom synthesis of (S)-Trifluoroisopropylamine for specialty chemical applications, flexible scale options

Synthonix’s modular synthesis platform allows rapid iteration of chiral fluorinated intermediates, catering to both academic laboratories and industrial clients seeking bespoke solutions.

Sustainability Initiatives:

• Use of bio‑derived reagents in asymmetric catalysis.
• Zero‑waste laboratory protocols for small‑scale syntheses.
• Collaboration with universities on sustainable fluorination research.

---

7️⃣ 4. Oakwood Products, Inc.

Headquarters: Newark, USA
Key Offering: Technical‑grade (S)-Trifluoroisopropylamine for agrochemical intermediates and fine chemical synthesis

Oakwood’s production capacity supports both research and commercial demands, with a focus on maintaining high optical purity while keeping unit costs competitive.

Sustainability Initiatives:

• Implementation of closed‑loop solvent recovery.
• Adoption of energy‑efficient catalytic processes.
• Participation in regional chemical safety programs.

---

6️⃣ 5. Capot Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Enantiopure (S)-Trifluoroisopropylamine for generic pharmaceutical manufacturing, scalable production lines

Capot’s rapid expansion in China’s fine‑chemical sector has positioned it as a key supplier for generic drug developers seeking cost‑effective chiral intermediates.

Sustainability Initiatives:

• Adoption of green fluorination catalysts.
• Reduction of volatile organic compound emissions.
• Engagement with local regulatory bodies to streamline compliance.

---

5️⃣ 6. Hairui Fine Chemicals

Headquarters: Shenzhen, China
Key Offering: High‑purity (S)-Trifluoroisopropylamine for pharmaceutical and agrochemical intermediates, rapid turnaround service

Hairui’s focus on lean manufacturing and automation has enabled it to meet the growing demand for chiral fluorinated building blocks across Asia.

Sustainability Initiatives:

• Implementation of renewable energy in production facilities.
• Use of recyclable packaging for bulk shipments.
• Participation in regional chemical safety initiatives.

---

4️⃣ 7. Pharmablock Sciences Co., Ltd.

Headquarters: Beijing, China
Key Offering: Custom‑grade (S)-Trifluoroisopropylamine for research and early‑stage drug discovery, flexible purity options

Pharmablock’s collaborative approach with academic institutions has fostered rapid development of novel fluorinated therapeutics, positioning it as a preferred partner for exploratory chemistry.

Sustainability Initiatives:

• Adoption of solvent‑free synthesis protocols.
• Investment in carbon capture technologies.
• Support of green chemistry educational programs.

---

3️⃣ 8. Biosynth AG

Headquarters: Basel, Switzerland
Key Offering: High‑purity (S)-Trifluoroisopropylamine for biopharmaceutical applications, cGMP‑compliant production

Biosynth’s expertise in enzyme‑mediated chiral resolution allows it to deliver consistent optical purity, essential for biologically active small molecules.

Sustainability Initiatives:

• Use of enzymatic catalysts to minimize hazardous reagents.
• Implementation of water‑recycling systems in manufacturing.
• Partnerships with sustainability research institutes.

---

2️⃣ 9. Manchester Organics Ltd.

Headquarters: Manchester, UK
Key Offering: Custom synthesis of (S)-Trifluoroisopropylamine for specialty chemical projects, rapid prototyping services

Manchester Organics provides tailored solutions for niche applications, combining advanced chiral chemistry with flexible scale options.

Sustainability Initiatives:

• Adoption of renewable feedstocks for fluorination reactions.
• Reduction of hazardous waste through process optimization.
• Engagement with local environmental agencies.

---

1️⃣ 10. Central Glass Co., Ltd.

Headquarters: Osaka, Japan
Key Offering: High‑purity (S)-Trifluoroisopropylamine for glass‑based pharmaceutical packaging and specialty coatings

Central Glass’s unique integration of chiral fluorinated intermediates into packaging materials supports advanced drug delivery systems with improved stability.

Sustainability Initiatives:

• Use of recyclable glass containers for bulk shipments.
• Implementation of low‑energy manufacturing processes.
• Collaboration with sustainability certification bodies.

---

Download FREE Sample Report:
(S)-Trifluoroisopropylamine (CAS 125278-10-6) Market – View in Detailed Research Report

Get Full Report:
(S)-Trifluoroisopropylamine (CAS 125278-10-6) Market – View in Detailed Research Report

---

Outlook

Analysts project that the integration of chiral fluorinated intermediates will continue to shape the evolution of drug discovery and agrochemical development. The continued focus on precision medicine and the need for robust metabolic profiles in new therapeutics are expected to sustain demand for high‑purity (S)-Trifluoroisopropylamine. In parallel, the expansion of CDMO capabilities and the adoption of flow‑based fluorination will lower entry barriers for smaller players, potentially broadening the supply base.

---

Future Trends

Emerging research into late‑stage fluorination and biocatalytic approaches is likely to reduce the reliance on pre‑fluorinated building blocks, creating a competitive dynamic that could drive innovation in synthetic routes. Additionally, the growing emphasis on green chemistry and circular economy principles will push manufacturers to adopt solvent‑free processes and renewable catalysts, aligning product development with regulatory and market expectations for sustainability.